<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01880177</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00068783</org_study_id>
    <secondary_id>7R01HL114055-03</secondary_id>
    <nct_id>NCT01880177</nct_id>
  </id_info>
  <brief_title>Developing a COPD Case Finding Methodology for Primary Care</brief_title>
  <official_title>A Study Designed to Develop and Validate a New Screening Measure for Identifying Undiagnosed At-Risk COPD Cases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United BioSource Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this qualitative work is to inform the content and structure of a new
      screening measure for identifying undiagnosed at-risk COPD cases in primary care and support
      content validity of the measure. This work will build on the results of a comprehensive
      literature review and data mining analyses by identifying the symptomatic and health event
      experiences of at-risk and newly diagnosed patients, as described by the patients themselves.
      Specific objectives are as follows:

      Objective 1: To elicit concepts and symptom descriptions of COPD from patients with a recent
      diagnosis of COPD and those without a diagnosis but with risk factors for the disease. The
      qualitative information obtained in these focus groups will be used to develop a new
      questionnaire for identifying undiagnosed at-risk COPD cases in various clinic settings.

      Objective 2: To review the new questionnaire with a new set of participants with a recent
      COPD diagnosis or those at risk for COPD to ensure that: (a) the instructions are clear, (b)
      the content of each question is appropriate and understandable to participants, (c) the
      intended connotation of each questions is consistent with participants' interpretation or
      assigned meaning, and (d) to assure that content is not seen as redundant across items. This
      will be done through one-on-one cognitive interviews.

      Objective 3: To gather data on the ease/difficulty of peak flow meter use by people without
      or with a new diagnosis of COPD and the consistency of readings between electronic and
      mechanical readings in these patients. This information will be used to inform the
      development of peak-flow meter instructions for use as part of the screening methodology.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>COPD Case Finding Tool</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">346</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease (COPD)</condition>
  <arm_group>
    <arm_group_label>Current smokers</arm_group_label>
    <description>Current smokers (&gt;10 pk yrs.)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ex-smokers</arm_group_label>
    <description>Ex-smokers with a history of &gt;10 pk yrs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Never-smokers</arm_group_label>
    <description>Never-smokers, defined as ≤100 cigarettes/pipes/cigars over life</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be recruited through multiple clinic settings, i.e., pulmonology clinics,
        internal medicine clinics, and primary care/family medicine clinics.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. Age ≥40 years

          -  2. Current smokers (&gt;10 pk yrs.) or Ex-smokers with a history of &gt;10 pk yrs. or
             Never-smokers, defined as ≤100 cigarettes/pipes/cigars over life

          -  3. Stable state PFT values from within the last 12 months available or obtainable

          -  4. Willing and able to attend the focus group session or cognitive interview

          -  5. Able to read and speak in English

          -  6. Willing and able to provide written Informed Consent

        Exclusion Criteria:

          -  1. Cognitive impairment, hearing or sight difficulty, or severe psychopathology that
             could interfere with ability to participate in the study

          -  2. Patient was hospitalized for respiratory infection within the past 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fernando J Martinez, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nancy K Leidy, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>United BioSource Corporation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Mannino, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kentucky</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan Health System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UNMC College of Medicine</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical center / New York Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. Respir Care. 2002 Oct;47(10):1184-99.</citation>
    <PMID>12354338</PMID>
  </reference>
  <reference>
    <citation>Centers for Disease Control and Prevention (CDC). Deaths from chronic obstructive pulmonary disease--United States, 2000-2005. MMWR Morb Mortal Wkly Rep. 2008 Nov 14;57(45):1229-32.</citation>
    <PMID>19008792</PMID>
  </reference>
  <reference>
    <citation>Brown DW, Croft JB, Greenlund KJ, Giles WH. Trends in hospitalization with chronic obstructive pulmonary disease-United States, 1990-2005. COPD. 2010 Feb;7(1):59-62. doi: 10.3109/15412550903499548.</citation>
    <PMID>20214464</PMID>
  </reference>
  <reference>
    <citation>Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000 Jun 12;160(11):1683-9.</citation>
    <PMID>10847262</PMID>
  </reference>
  <reference>
    <citation>Anzueto A, Sethi S, Martinez FJ. Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007 Oct 1;4(7):554-64. Review.</citation>
    <PMID>17878469</PMID>
  </reference>
  <reference>
    <citation>Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010 Sep 16;363(12):1128-38. doi: 10.1056/NEJMoa0909883.</citation>
    <PMID>20843247</PMID>
  </reference>
  <reference>
    <citation>Roche N, Gaillat J, Garre M, Meunier JP, Lemaire N, Bendjenana H. Acute respiratory illness as a trigger for detecting chronic bronchitis in adults at risk of COPD: a primary care survey. Prim Care Respir J. 2010 Dec;19(4):371-7. doi: 10.4104/pcrj.2010.00042.</citation>
    <PMID>20842324</PMID>
  </reference>
  <reference>
    <citation>Langsetmo L, Platt RW, Ernst P, Bourbeau J. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med. 2008 Feb 15;177(4):396-401. Epub 2007 Nov 29.</citation>
    <PMID>18048806</PMID>
  </reference>
  <reference>
    <citation>Gruffydd-Jones K, Loveridge C. The 2010 NICE COPD Guidelines: how do they compare with the GOLD guidelines? Prim Care Respir J. 2011 Jun;20(2):199-204. doi: 10.4104/pcrj.2011.00011.</citation>
    <PMID>21437566</PMID>
  </reference>
  <reference>
    <citation>Wilt TJ, Niewoehner D, MacDonald R, Kane RL. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline. Ann Intern Med. 2007 Nov 6;147(9):639-53. Review.</citation>
    <PMID>17975187</PMID>
  </reference>
  <reference>
    <citation>Postma D, Anzueto A, Calverley P, Jenkins C, Make BJ, Sciurba FC, Similowski T, van der Molen T, Eriksson G. A new perspective on optimal care for patients with COPD. Prim Care Respir J. 2011 Jun;20(2):205-9. doi: 10.4104/pcrj.2011.00041.</citation>
    <PMID>21559550</PMID>
  </reference>
  <reference>
    <citation>Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JA Jr, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Make B, Marchetti N, Martinez FJ, Madinger NE, McEvoy C, Niewoehner DE, Porsasz J, Price CS, Reilly J, Scanlon PD, Sciurba FC, Scharf SM, Washko GR, Woodruff PG, Anthonisen NR; COPD Clinical Research Network. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011 Aug 25;365(8):689-98. doi: 10.1056/NEJMoa1104623. Erratum in: N Engl J Med. 2012 Apr 5;366(14):1356.</citation>
    <PMID>21864166</PMID>
  </reference>
  <reference>
    <citation>Wilt TJ, Niewoehner D, Kim C, Kane RL, Linabery A, Tacklind J, Macdonald R, Rutks I. Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). Evid Rep Technol Assess (Summ). 2005 Aug;(121):1-7. Review.</citation>
    <PMID>16238364</PMID>
  </reference>
  <reference>
    <citation>Van Schayck CP, Loozen JM, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ. 2002 Jun 8;324(7350):1370.</citation>
    <PMID>12052807</PMID>
  </reference>
  <reference>
    <citation>Freeman D, Nordyke RJ, Isonaka S, Nonikov DV, Maroni JM, Price D, Halbert RJ. Questions for COPD diagnostic screening in a primary care setting. Respir Med. 2005 Oct;99(10):1311-8. Epub 2005 Apr 18.</citation>
    <PMID>16140231</PMID>
  </reference>
  <reference>
    <citation>Price DB, Tinkelman DG, Halbert RJ, Nordyke RJ, Isonaka S, Nonikov D, Juniper EF, Freeman D, Hausen T, Levy ML, Ostrem A, van der Molen T, van Schayck CP. Symptom-based questionnaire for identifying COPD in smokers. Respiration. 2006;73(3):285-95. Epub 2005 Dec 5.</citation>
    <PMID>16330875</PMID>
  </reference>
  <reference>
    <citation>Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D, Juniper EF, Freeman D, Hausen T, Levy ML, Ostrem A, van der Molen T, van Schayck CP. Symptom-based questionnaire for differentiating COPD and asthma. Respiration. 2006;73(3):296-305. Epub 2005 Dec 5.</citation>
    <PMID>16330874</PMID>
  </reference>
  <reference>
    <citation>Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ; COPD Questionnaire Study Group. Scoring system and clinical application of COPD diagnostic questionnaires. Chest. 2006 Jun;129(6):1531-9.</citation>
    <PMID>16778271</PMID>
  </reference>
  <reference>
    <citation>Kotz D, Nelemans P, van Schayck CP, Wesseling GJ. External validation of a COPD diagnostic questionnaire. Eur Respir J. 2008 Feb;31(2):298-303. Epub 2007 Oct 24.</citation>
    <PMID>17959636</PMID>
  </reference>
  <reference>
    <citation>Martinez FJ, Raczek AE, Seifer FD, Conoscenti CS, Curtice TG, D'Eletto T, Cote C, Hawkins C, Phillips AL; COPD-PS Clinician Working Group. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008 Apr;5(2):85-95. doi: 10.1080/15412550801940721.</citation>
    <PMID>18415807</PMID>
  </reference>
  <reference>
    <citation>Yawn BP, Mapel DW, Mannino DM, Martinez FJ, Donohue JF, Hanania NA, Kosinski M, Rendas-Baum R, Mintz M, Samuels S, Dalal AA; Lung Function Questionnaire Working Group. Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. Int J Chron Obstruct Pulmon Dis. 2010 Feb 18;5:1-10.</citation>
    <PMID>20368906</PMID>
  </reference>
  <reference>
    <citation>Hanania NA, Mannino DM, Yawn BP, Mapel DW, Martinez FJ, Donohue JF, Kosinski M, Rendas-Baum R, Mintz M, Samuels S, Jhingran P, Dalal AA. Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respir Med. 2010 Aug;104(8):1160-70. doi: 10.1016/j.rmed.2010.02.009. Epub 2010 Mar 11.</citation>
    <PMID>20226647</PMID>
  </reference>
  <reference>
    <citation>Frith P, Crockett A, Beilby J, Marshall D, Attewell R, Ratnanesan A, Gavagna G. Simplified COPD screening: validation of the PiKo-6® in primary care. Prim Care Respir J. 2011 Jun;20(2):190-8, 2 p following 198. doi: 10.4104/pcrj.2011.00040.</citation>
    <PMID>21597667</PMID>
  </reference>
  <reference>
    <citation>Sichletidis L, Spyratos D, Papaioannou M, Chloros D, Tsiotsios A, Tsagaraki V, Haidich AB. A combination of the IPAG questionnaire and PiKo-6® flow meter is a valuable screening tool for COPD in the primary care setting. Prim Care Respir J. 2011 Jun;20(2):184-9, 1 p following 189. doi: 10.4104/pcrj.2011.00038.</citation>
    <PMID>21597666</PMID>
  </reference>
  <reference>
    <citation>Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O'Neill R, Kennedy DL. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007 Nov-Dec;10 Suppl 2:S125-37. Review.</citation>
    <PMID>17995471</PMID>
  </reference>
  <reference>
    <citation>Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009 Sep;34(3):648-54. doi: 10.1183/09031936.00102509.</citation>
    <PMID>19720809</PMID>
  </reference>
  <reference>
    <citation>Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.</citation>
    <PMID>1593914</PMID>
  </reference>
  <reference>
    <citation>Leidy NK, Vernon M. Perspectives on patient-reported outcomes : content validity and qualitative research in a changing clinical trial environment. Pharmacoeconomics. 2008;26(5):363-70.</citation>
    <PMID>18429654</PMID>
  </reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2013</study_first_submitted>
  <study_first_submitted_qc>June 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 18, 2013</study_first_posted>
  <last_update_submitted>May 10, 2016</last_update_submitted>
  <last_update_submitted_qc>May 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Fernando J. Martinez, MD, MS</investigator_full_name>
    <investigator_title>Professor, Department of Internal Medicine at University of Michigan</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

